Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.

Chronic neuropathic pain (NP) is a growing clinical problem for which effective treatments, aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are emerging as potentially promising agents to manage neuroimmune effects associated with nociception. In particular, Δ...

Full description

Bibliographic Details
Main Authors: Katja Linher-Melville, Yong Fang Zhu, Jesse Sidhu, Natalka Parzei, Ayesha Shahid, Gireesh Seesankar, Danny Ma, Zhi Wang, Natalie Zacal, Manu Sharma, Vikas Parihar, Ramesh Zacharias, Gurmit Singh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0234176
id doaj-75a210e0d77a4ab3a87d8ba676ced0b2
record_format Article
spelling doaj-75a210e0d77a4ab3a87d8ba676ced0b22021-03-03T21:51:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01156e023417610.1371/journal.pone.0234176Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.Katja Linher-MelvilleYong Fang ZhuJesse SidhuNatalka ParzeiAyesha ShahidGireesh SeesankarDanny MaZhi WangNatalie ZacalManu SharmaVikas PariharRamesh ZachariasGurmit SinghChronic neuropathic pain (NP) is a growing clinical problem for which effective treatments, aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are emerging as potentially promising agents to manage neuroimmune effects associated with nociception. In particular, Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination are being considered as therapeutic alternatives for treatment of NP. This study aimed to examine whether sex affects long-term outcomes on persistent mechanical hypersensitivity 7 weeks after ceasing cannabinoid administration. Clinically relevant low doses of THC, CBD, and a 1:1 combination of THC:CBD extracts, in medium chain triglyceride (MCT) oil, were orally gavaged for 14 consecutive days to age-matched groups of male and female sexually mature Sprague Dawley rats. Treatments commenced one day after surgically inducing a pro-nociceptive state using a peripheral sciatic nerve cuff. The analgesic efficacy of each phytocannabinoid was assessed relative to MCT oil using hind paw mechanical behavioural testing once a week for 9 weeks. In vivo intracellular electrophysiology was recorded at endpoint to characterize soma threshold changes in primary afferent sensory neurons within dorsal root ganglia (DRG) innervated by the affected sciatic nerve. The thymus, spleen, and DRG were collected post-sacrifice and analyzed for long-term effects on markers associated with T lymphocytes at the RNA level using qPCR. Administration of cannabinoids, particularly the 1:1 combination of THC, elicited a sustained mechanical anti-hypersensitive effect in males with persistent peripheral NP, which corresponded to beneficial changes in myelinated Aβ mechanoreceptive fibers. Specific immune cell markers associated with T cell differentiation and pro-inflammatory cytokines, previously implicated in repair processes, were differentially up-regulated by cannabinoids in males treated with cannabinoids, but not in females, warranting further investigation into sexual dimorphisms that may underlie treatment outcomes.https://doi.org/10.1371/journal.pone.0234176
collection DOAJ
language English
format Article
sources DOAJ
author Katja Linher-Melville
Yong Fang Zhu
Jesse Sidhu
Natalka Parzei
Ayesha Shahid
Gireesh Seesankar
Danny Ma
Zhi Wang
Natalie Zacal
Manu Sharma
Vikas Parihar
Ramesh Zacharias
Gurmit Singh
spellingShingle Katja Linher-Melville
Yong Fang Zhu
Jesse Sidhu
Natalka Parzei
Ayesha Shahid
Gireesh Seesankar
Danny Ma
Zhi Wang
Natalie Zacal
Manu Sharma
Vikas Parihar
Ramesh Zacharias
Gurmit Singh
Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
PLoS ONE
author_facet Katja Linher-Melville
Yong Fang Zhu
Jesse Sidhu
Natalka Parzei
Ayesha Shahid
Gireesh Seesankar
Danny Ma
Zhi Wang
Natalie Zacal
Manu Sharma
Vikas Parihar
Ramesh Zacharias
Gurmit Singh
author_sort Katja Linher-Melville
title Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
title_short Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
title_full Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
title_fullStr Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
title_full_unstemmed Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
title_sort evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of δ9-tetrahydrocannabinol (thc), cannabidiol (cbd), and their 1:1 combination.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Chronic neuropathic pain (NP) is a growing clinical problem for which effective treatments, aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are emerging as potentially promising agents to manage neuroimmune effects associated with nociception. In particular, Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination are being considered as therapeutic alternatives for treatment of NP. This study aimed to examine whether sex affects long-term outcomes on persistent mechanical hypersensitivity 7 weeks after ceasing cannabinoid administration. Clinically relevant low doses of THC, CBD, and a 1:1 combination of THC:CBD extracts, in medium chain triglyceride (MCT) oil, were orally gavaged for 14 consecutive days to age-matched groups of male and female sexually mature Sprague Dawley rats. Treatments commenced one day after surgically inducing a pro-nociceptive state using a peripheral sciatic nerve cuff. The analgesic efficacy of each phytocannabinoid was assessed relative to MCT oil using hind paw mechanical behavioural testing once a week for 9 weeks. In vivo intracellular electrophysiology was recorded at endpoint to characterize soma threshold changes in primary afferent sensory neurons within dorsal root ganglia (DRG) innervated by the affected sciatic nerve. The thymus, spleen, and DRG were collected post-sacrifice and analyzed for long-term effects on markers associated with T lymphocytes at the RNA level using qPCR. Administration of cannabinoids, particularly the 1:1 combination of THC, elicited a sustained mechanical anti-hypersensitive effect in males with persistent peripheral NP, which corresponded to beneficial changes in myelinated Aβ mechanoreceptive fibers. Specific immune cell markers associated with T cell differentiation and pro-inflammatory cytokines, previously implicated in repair processes, were differentially up-regulated by cannabinoids in males treated with cannabinoids, but not in females, warranting further investigation into sexual dimorphisms that may underlie treatment outcomes.
url https://doi.org/10.1371/journal.pone.0234176
work_keys_str_mv AT katjalinhermelville evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT yongfangzhu evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT jessesidhu evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT natalkaparzei evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT ayeshashahid evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT gireeshseesankar evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT dannyma evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT zhiwang evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT nataliezacal evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT manusharma evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT vikasparihar evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT rameshzacharias evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
AT gurmitsingh evaluationofthepreclinicalanalgesicefficacyofnaturallyderivedorallyadministeredoilformsofd9tetrahydrocannabinolthccannabidiolcbdandtheir11combination
_version_ 1714814676765769728